Omission of Histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer : Results from a nationwide studyLUNDIN, J; LUNDIN, M; HOLLI, K et al.Journal of clinical oncology. 2001, Vol 19, Num 1, pp 28-36, issn 0732-183XArticle

Artificial neural networks applied to survival prediction in breast cancerLUNDIN, M; LUNDIN, J; BURKE, H. B et al.Oncology. 1999, Vol 57, Num 4, pp 281-286, issn 0030-2414Article

Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancerCARPELAN-HOLMSTRÖM, M; HAGLUND, C; LUNDIN, J et al.British journal of cancer. 1996, Vol 74, Num 6, pp 925-929, issn 0007-0920Article

Prognostic value of immunohistochemical expression of p53 patients with pancreatic cancerLUNDIN, J; NORDLING, S; VON BOGUSLAWSKY, K et al.Oncology. 1996, Vol 53, Num 2, pp 104-111, issn 0030-2414Article

Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of richter transformationKARLSSUN, C; NORIN, S; KIMBY, E et al.Leukemia. 2006, Vol 20, Num 12, pp 2204-2207, issn 0887-6924, 4 p.Article

Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemiaLUNDIN, J; PORWIT-MACDONALD, A; ROSSMANN, E. D et al.Leukemia. 2004, Vol 18, Num 3, pp 484-490, issn 0887-6924, 7 p.Article

Collaborative learning in mobile workLUNDIN, J; MAGNUSSON, M.Journal of computer assisted learning (Print). 2003, Vol 19, Num 3, pp 273-283, issn 0266-4909, 11 p.Article

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMFPOIKONEN, P; SAARTO, T; LUNDIN, J et al.British journal of cancer. 1999, Vol 80, Num 11, pp 1763-1766, issn 0007-0920Article

Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9LUNDIN, J; ROBERTS, P. J; KUUSELA, P et al.Anticancer research. 1995, Vol 15, Num 5B, pp 2181-2186, issn 0250-7005Article

Surface composition of iron oxide catalysts used for styrene production : an Auger electron spectroscopy/scanning electron microscopy studyLUNDIN, J; HOLMLID, L; MENON, P. G et al.Industrial & engineering chemistry research. 1993, Vol 32, Num 11, pp 2500-2505, issn 0888-5885Article

COMPUTERIZED LITERATURE SCREENING. A POSSIBLE METHOD FOR VERIFICATION OF A CHEMICAL DISARMAMENT TREATYBYFORS I; ENANDER PERSSON I; LUNDIN J et al.1975; F.O.A. REP.; SWED.; DA. 1975; VOL. 9; NO 7; PP. 1-10; BIBL. 12 REF.; ISBN 9170560382Serial Issue

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies : a randomized multicenter studyHEDENUS, M; BIRGEGARD, G; NÄSMAN, P et al.Leukemia. 2007, Vol 21, Num 4, pp 627-632, issn 0887-6924, 6 p.Article

Tenascin-C Expression and Its Prognostic Significance in Colorectal CancerLUNDIN, M; NORDLING, S; LUNDIN, J et al.Oncology. 2007, Vol 72, Num 5-6, pp 403-409, issn 0030-2414, 7 p.Article

Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLLKOKHAEI, P; CHOUDHURY, A; MAHDIAN, R et al.Leukemia. 2004, Vol 18, Num 11, pp 1810-1815, issn 0887-6924, 6 p.Article

Interleukin 4 therapy for patients with chronic lymphocytic leukaemia : a phase I/II studyLUNDIN, J; KIMBY, E; BERGMANN, L et al.British journal of haematology. 2001, Vol 112, Num 1, pp 155-160, issn 0007-1048Article

Tissue expression of human chorionic gonadotropin β predicts outcome in colorectal cancer : A comparison with serum expressionLUNDIN, M; NORDLING, S; LUNDIN, J et al.International journal of cancer. 2001, Vol 95, Num 1, pp 18-22, issn 0020-7136Article

Serum tumour markers CA 15-3, TPA, TPS, hCGβ and TATI in the monitoring of chemotherapy response in metastatic breast cancerSJÖSTRÖM, J; ALFTHAN, H; JOENSUU, H et al.Scandinavian journal of clinical & laboratory investigation. 2001, Vol 61, Num 6, pp 431-441, issn 0036-5513Article

Concentration of free hCGβ subunit in serum as a prognostic marker for squamous-cell carcinoma of the oral cavity and oropharynxHEDSTRÖM, J; GRENMAN, R; RAMSAY, H et al.International journal of cancer. 1999, Vol 84, Num 5, pp 525-528, issn 0020-7136Article

A risk score for predicting outcome in patients with gastric cancer, based on stage, sialyl-Tn immunoreactivity and ploidy : A multivariate analysisVICTORZON, M; LUNDIN, J; HAGLUND, C et al.International journal of cancer. 1996, Vol 67, Num 2, pp 190-193, issn 0020-7136Article

Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancerCARPELAN-HOLMSTRÖM, M; HAGLUND, C; LUNDIN, J et al.European journal of cancer (1990). 1996, Vol 32, Num 7, pp 1156-1161, issn 0959-8049Article

Kinetics for potassium desorption from an iron oxide catalyst studied by field reversalLUNDIN, J; HANSSON, T; PETTERSSON, J. B. C et al.Applied surface science. 1994, Vol 74, Num 4, pp 343-349, issn 0169-4332Article

Expression and prognostic value of transcription factor PROXII in colorectal cancerSKOG, M; BONO, P; HAGLUND, C. H et al.British journal of cancer. 2011, Vol 105, Num 9, pp 1346-1351, issn 0007-0920, 6 p.Article

Extending the phenotype of recurrent rearrangements of 16p11.2: Deletions in mentally retarded patients without autism and in normal individualsBIJLSMA, E. K; GIJSBERS, A. C. J; LOEYS, B et al.European journal of medical genetics. 2009, Vol 52, Num 2-3, pp 77-87, issn 1769-7212, 11 p.Article

Quantum vacuum experiments using high intensity lasersMARKLUND, M; LUNDIN, J.The European physical journal. D, Atomic, molecular and optical physics (Print). 2009, Vol 55, Num 2, pp 319-326, issn 1434-6060, 8 p.Article

Page / 2